
Christine Eng, MD, discusses how earlier genome testing, multi-omic tools, rapid sequencing, and improved access can shorten diagnostic timelines and guide care.
Christine Eng, MD, is chief medical officer at Baylor Genetics.

Christine Eng, MD, discusses how earlier genome testing, multi-omic tools, rapid sequencing, and improved access can shorten diagnostic timelines and guide care.

Christine Eng, MD, discusses insurance, access, logistics, and result interpretation challenges affecting effective use of exome and genome sequencing.

New AAP guidance supports early use of exome and genome sequencing, offering higher diagnostic yield and faster results for children with developmental delay and ID.

Published: December 5th 2025 | Updated: